Elevance Health, Inc.
ELV
$547.71
$3.820.70%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.25B | 856.00M | 1.29B | 1.85B | 1.99B |
| Total Depreciation and Amortization | 331.00M | -261.00M | 426.00M | 433.00M | 462.00M |
| Total Amortization of Deferred Charges | -- | 685.00M | -- | -- | -- |
| Total Other Non-Cash Items | 389.00M | 105.00M | 688.00M | 107.00M | -36.00M |
| Change in Net Operating Assets | -988.00M | -4.36B | 210.00M | -443.00M | 4.05B |
| Cash from Operations | 1.98B | -2.97B | 2.61B | 1.95B | 6.47B |
| Capital Expenditure | -279.00M | -326.00M | -319.00M | -350.00M | -301.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.12B | 18.00M | 81.00M | -13.00M | -1.64B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -911.00M | -721.00M | -449.00M | -309.00M | -1.25B |
| Cash from Investing | -2.31B | -1.03B | -687.00M | -672.00M | -3.18B |
| Total Debt Issued | 1.56B | 339.00M | -90.00M | -235.00M | 2.90B |
| Total Debt Repaid | -586.00M | 499.00M | -107.00M | -239.00M | -2.40B |
| Issuance of Common Stock | 97.00M | 40.00M | 31.00M | 38.00M | 43.00M |
| Repurchase of Common Stock | -666.00M | -928.00M | -480.00M | -647.00M | -720.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -379.00M | -346.00M | -348.00M | -350.00M | -351.00M |
| Other Financing Activities | 4.00M | 2.00M | 0.00 | 3.00M | 2.00M |
| Cash from Financing | 32.00M | -394.00M | -994.00M | -1.43B | -531.00M |
| Foreign Exchange rate Adjustments | -- | 1.00M | -4.00M | 1.00M | 1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -300.00M | -4.39B | 928.00M | -151.00M | 2.76B |
